These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
126 related items for PubMed ID: 17804303
1. Requirement of intact sympathetic transmission for the ocular hypotensive effects of melatonin and 5-MCA-NAT. Alarma-Estrany P, Crooke A, Peral A, Pintor J. Auton Neurosci; 2007 Dec 30; 137(1-2):63-6. PubMed ID: 17804303 [Abstract] [Full Text] [Related]
2. Ophthalmic formulations of the intraocular hypotensive melatonin agent 5-MCA-NAT. Andrés-Guerrero V, Alarma-Estrany P, Molina-Martínez IT, Peral A, Herrero-Vanrell R, Pintor J. Exp Eye Res; 2009 Mar 30; 88(3):504-11. PubMed ID: 19056382 [Abstract] [Full Text] [Related]
3. Involvement of carbonic anhydrases in the ocular hypotensive effect of melatonin analogue 5-MCA-NAT. Crooke A, Huete-Toral F, Martínez-Águila A, Martín-Gil A, Pintor J. J Pineal Res; 2012 Apr 30; 52(3):265-70. PubMed ID: 22107075 [Abstract] [Full Text] [Related]
4. Sympathetic nervous system modulates the ocular hypotensive action of MT2-melatonin receptors in normotensive rabbits. Alarma-Estrany P, Crooke A, Mediero A, Peláez T, Pintor J. J Pineal Res; 2008 Nov 30; 45(4):468-75. PubMed ID: 18673419 [Abstract] [Full Text] [Related]
5. Melatonin and its analog 5-methoxycarbonylamino-N-acetyltryptamine potentiate adrenergic receptor-mediated ocular hypotensive effects in rabbits: significance for combination therapy in glaucoma. Crooke A, Huete-Toral F, Martínez-Águila A, Martín-Gil A, Pintor J. J Pharmacol Exp Ther; 2013 Jul 30; 346(1):138-45. PubMed ID: 23591996 [Abstract] [Full Text] [Related]
6. Regulation of ocular adrenoceptor genes expression by 5-MCA-NAT: implications for glaucoma treatment. Crooke A, Huete-Toral F, Martínez-Águila A, Alarma-Estrany P, Pintor J. Pharmacogenet Genomics; 2011 Sep 30; 21(9):587-9. PubMed ID: 21705965 [Abstract] [Full Text] [Related]
7. Effect of Melatonin and 5-Methoxycarbonylamino-N-Acetyltryptamine on the Intraocular Pressure of Normal and Glaucomatous Mice. Martínez-Águila A, Fonseca B, Pérez de Lara MJ, Pintor J. J Pharmacol Exp Ther; 2016 May 30; 357(2):293-9. PubMed ID: 26941171 [Abstract] [Full Text] [Related]
8. Design of novel melatonin analogs for the reduction of intraocular pressure in normotensive rabbits. Alarma-Estrany P, Guzman-Aranguez A, Huete F, Peral A, Plourde R, Pelaez T, Yerxa B, Pintor J. J Pharmacol Exp Ther; 2011 Jun 30; 337(3):703-9. PubMed ID: 21368006 [Abstract] [Full Text] [Related]
9. Ocular hypotensive effects of melatonin receptor agonists in the rabbit: further evidence for an MT3 receptor. Pintor J, Peláez T, Hoyle CH, Peral A. Br J Pharmacol; 2003 Mar 30; 138(5):831-6. PubMed ID: 12642384 [Abstract] [Full Text] [Related]
10. The use of mucoadhesive polymers to enhance the hypotensive effect of a melatonin analogue, 5-MCA-NAT, in rabbit eyes. Andrés-Guerrero V, Molina-Martínez IT, Peral A, de las Heras B, Pintor J, Herrero-Vanrell R. Invest Ophthalmol Vis Sci; 2011 Mar 18; 52(3):1507-15. PubMed ID: 21087964 [Abstract] [Full Text] [Related]
11. Molecular and cellular pharmacological properties of 5-methoxycarbonylamino-N-acetyltryptamine (MCA-NAT): a nonspecific MT3 ligand. Vincent L, Cohen W, Delagrange P, Boutin JA, Nosjean O. J Pineal Res; 2010 Apr 18; 48(3):222-229. PubMed ID: 20210850 [Abstract] [Full Text] [Related]
12. New treatments for ocular hypertension. Mediero A, Alarma-Estrany P, Pintor J. Auton Neurosci; 2009 May 11; 147(1-2):14-9. PubMed ID: 19176290 [Abstract] [Full Text] [Related]
13. Melatonin receptors trigger cAMP production and inhibit chloride movements in nonpigmented ciliary epithelial cells. Huete-Toral F, Crooke A, Martínez-Águila A, Pintor J. J Pharmacol Exp Ther; 2015 Jan 11; 352(1):119-28. PubMed ID: 25344385 [Abstract] [Full Text] [Related]
14. Is ocular melatonin regulated by the adrenergic system? Rohde BH, Chiou GC. Ophthalmic Res; 1987 Jan 11; 19(3):178-86. PubMed ID: 3658329 [Abstract] [Full Text] [Related]
15. Design and synthesis of benzofuranic derivatives as new ligands at the melatonin-binding site MT3. Ettaoussi M, Péres B, Klupsch F, Delagrange P, Boutin JA, Renard P, Caignard DH, Chavatte P, Berthelot P, Lesieur D, Yous S. Bioorg Med Chem; 2008 May 01; 16(9):4954-62. PubMed ID: 18372181 [Abstract] [Full Text] [Related]
16. Hybrid formulations of liposomes and bioadhesive polymers improve the hypotensive effect of the melatonin analogue 5-MCA-NAT in rabbit eyes. Quinteros D, Vicario-de-la-Torre M, Andrés-Guerrero V, Palma S, Allemandi D, Herrero-Vanrell R, Molina-Martínez IT. PLoS One; 2014 May 01; 9(10):e110344. PubMed ID: 25329636 [Abstract] [Full Text] [Related]
17. Diadenosine tetraphosphate protects sympathetic terminals from 6-hydroxydopamine-induced degeneration in the eye. Hoyle CH, Pintor JJ. Acta Physiol (Oxf); 2010 Jun 01; 199(2):205-10. PubMed ID: 20121713 [Abstract] [Full Text] [Related]
18. 5-MCA-NAT does not act through NQO2 to reduce intraocular pressure in New-Zealand white rabbit. Alarma-Estrany P, Crooke A, Pintor J. J Pineal Res; 2009 Sep 01; 47(2):201-209. PubMed ID: 19627460 [Abstract] [Full Text] [Related]
19. The melatonin analog 5-MCA-NAT increases endogenous dopamine levels by binding NRH:quinone reductase enzyme in the developing chick retina. Sampaio Lde F, Mesquita FP, de Sousa PR, Silva JL, Alves CN. Int J Dev Neurosci; 2014 Nov 01; 38():119-26. PubMed ID: 25218627 [Abstract] [Full Text] [Related]
20. Involvement of melatonin MT(3) receptors in the regulation of intraocular pressure in rabbits. Pintor J, Martin L, Pelaez T, Hoyle CH, Peral A. Eur J Pharmacol; 2001 Mar 30; 416(3):251-4. PubMed ID: 11290376 [Abstract] [Full Text] [Related] Page: [Next] [New Search]